CUSIP: 82686Q101 | US | Healthcare · Biotechnology | Small Cap | 158 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/ARaymond Debbane with Invus Public Equities Advisors, LLC, Invus Global Management, LLC, Siren, L.L.C., +4 more | 9,934,314 | 7.0% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 201,900 | $1.8M | 0.0% | Core | Low | Edinburgh, United Kingdom | 2026-11-06 | |
| 195,958 | $2.1M | 0.0% | Core | Medium | London, United Kingdom | 2026-11-06 | |
| 40,107 | $438.4K | 0.0% | Value | Very High | Hong Kong, South Korea | 2026-10-16 | |
| 15,979 | $174.7K | 0.0% | Index | Very Low | Boston, MA | 2026-11-06 | |
| 15,027 | $164.2K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 11,207 | $122.5K | 0.0% | Index | Very Low | Foster City, CA | 2026-10-08 | |
| 8,572 | $92.6K | 0.0% | Growth | Medium | Shanghai, France | 2026-10-28 | |
| 4,761 | $52.0K | 0.0% | Growth | Very Low | Pittsburgh, PA | 2026-11-06 | |
| 4,000 | $43 | 0.0% | Growth | Very High | New York, NY | 2026-10-16 | |
| 2,401 | $26.2K | 0.0% | Growth | Low | Seoul, Malaysia | 2026-11-03 | |
| 1,906 | $20.8K | 0.0% | Index | Low | San Francisco, CA | 2026-11-03 | |
| 1,061 | $11.6K | 0.0% | Agg Growth | Medium | Guangzhou, France | 2026-10-26 | |
| 843 | $9.2K | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 | |
| 118 | $1.3K | 0.0% | ETF | Low | Concord, CA | 2026-10-21 | |
| 48 | $525 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 | |
| 18 | $197 | 0.0% | Index | Very Low | St. Louis, MO | 2026-10-20 |